Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections
Top Cited Papers
Open Access
- 13 February 2016
- journal article
- review article
- Published by Springer Science and Business Media LLC in Military Medical Research
- Vol. 3 (1), 1-10
- https://doi.org/10.1186/s40779-016-0074-5
Abstract
Bacterial vaginosis (BV) is a common vaginal disorder in women of reproductive age. Since the initial work of Leopoldo in 1953 and Gardner and Dukes in 1955, researchers have not been able to identify the causative etiologic agent of BV. There is increasing evidence, however, that BV occurs when Lactobacillus spp., the predominant species in healthy vaginal flora, are replaced by anaerobic bacteria, such as Gardenella vaginalis, Mobiluncus curtisii, M. mulieris, other anaerobic bacteria and/or Mycoplasma hominis. Worldwide, it estimated that 20–30 % of women of reproductive age attending sexually transmitted infection (STI) clinics suffer from BV, and that its prevalence can be as high as 50–60 % in high-risk populations (e.g., those who practice commercial sex work (CSW). Epidemiological data show that women are more likely to report BV if they: 1) have had a higher number of lifetime sexual partners; 2) are unmarried; 3) have engaged in their first intercourse at a younger age; 4) have engaged in CSW, and 5) practice regular douching. In the past decade, several studies have provided evidence on the contribution of sexual activity to BV. However, it is difficult to state that BV is a STI without being able to identify the etiologic agent. BV has also emerged as a public health problem due to its association with other STIs, including: human immunodeficiency virus (HIV), herpes simplex virus type 2 (HSV-2), Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). The most recent evidence on the association between BV and CT/NG infection comes from two secondary analyses of cohort data conducted among women attending STI clinics. Based on these studies, women with BV had a 1.8 and 1.9-fold increased risk for NG and CT infection, respectively. Taken together, BV is likely a risk factor or at least an important contributor to subsequent NG or CT infection in high-risk women. Additional research is required to determine whether this association is also present in other low-risk sexually active populations, such as among women in the US military. It is essential to conduct large scale cross-sectional or population-based case-control studies to investigate the role of BV as a risk factor for CT/NG infections. These studies could lead to the development of interventions aimed at reducing the burden associated with bacterial STIs worldwide.Keywords
Funding Information
- Global Emerging Infectious Surveillance and Response
This publication has 95 references indexed in Scilit:
- Behavioural and medical predictors of bacterial vaginosis recurrence among female sex workers: longitudinal analysis from a randomized controlled trialBMC Infectious Diseases, 2013
- The Microbiota of the Vagina and Its Influence on Women’s Health and DiseaseThe American Journal of the Medical Sciences, 2012
- Interpreting the epidemiology and natural history of bacterial vaginosis: Are we still confused?Anaerobe, 2011
- Severity of bacterial vaginosis and the risk of sexually transmitted infectionAmerican Journal of Obstetrics and Gynecology, 2011
- Bacterial Vaginosis Assessed by Gram Stain and Diminished Colonization Resistance to Incident Gonococcal, Chlamydial, and Trichomonal Genital InfectionThe Journal of Infectious Diseases, 2010
- Bacterial Vaginosis: Identifying Research Gaps Proceedings of a Workshop Sponsored by DHHS/NIH/NIAIDSexually Transmitted Diseases, 2010
- Personal Hygienic Behaviors and Bacterial VaginosisSexually Transmitted Diseases, 2010
- Women at risk for sexually transmitted diseases: correlates of intercourse without barrier contraceptionAmerican Journal of Obstetrics and Gynecology, 2007
- Findings Associated with Recurrence of Bacterial Vaginosis among Adolescents Attending Sexually Transmitted Diseases ClinicsJournal of Pediatric and Adolescent Gynecology, 2007
- A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseasesAmerican Journal of Obstetrics and Gynecology, 2007